摘要:
The subject matter of the present invention is a compound characterized in that it has the general formula (I): in which P 1 , X, n, A, L and L 1 are as defined in Claim 1. The present invention also relates to a process for preparing said compounds (I) and to the use thereof for targeting the cation-independent mannose 6-phosphate receptor (CI-M6PR). The subject matter of the invention is also a conjugate of formula (III): in which P 1 , X, n, A, L and L' 1 are as defined in Claim 6, and the use thereof: - in a method for therapeutic treatment of the human or animal body, in particular chosen from enzyme replacement therapy, photodynamic therapy or cancer treatment, and/or - in a method of diagnosis, in particular of diseases or of ailments associated with an increase or with a decrease in CI-M6PR expression.
摘要:
The invention relates to a method for the in vitro diagnosis of prostate cancer in a patient, characterised in that it comprises a step of measuring the expression level of the gene of the cation-independent mannose-6-phosphate receptor (CI-M6PR) in a sample of prostate tissue of the patient, the determination of overexpression of said CI-M6PR gene indicating the presence of prostate cancer in said patient.
摘要:
The invention relates to compounds of formula (I) : the groups A and B represent independently from each other -CH=CH-, or -C≡C-, the terms t, u, v, w represent, independently from each other, values ranging from 0 to 9, the groups Y 1 and Y 2 can represent independently from each other an alkyl group (linear, branched or substituted) carrying from 1 to 9 carbon atoms, the groups Z 1 , Z 2 , Z 3 , and Z 4 can represent independently from each other a chemically reactive group W, such as OH, NH 2 , SH, the groups Z 5 and Z 6 represent independently from each other a hydrogen atom, silica nanoparticles functionalized by these compounds, and their use as drugs.
摘要:
The invention relates to conjugates of products of interest and of compounds targeting the cation-independent mannose 6-phosphate receptor with a high affinity. The invention also relates to their applications, for instance in enzyme replacement therapies.
摘要:
The invention relates to nanovectors of formula (I) that can be used simultaneously for the targeting, imaging and treatment, by means of photodynamic therapy, of cancer cells, and to biodegradable silicon nanoparticles containing a variety of photosensitizing molecules, in particular porphyrins, capable of targeting diseased cells and inducing cell death by means of excitation in the near-infrared region (> 600 nm) in monophotonic and biphotonic modes. According to the invention, in formula (I), (AA) is a porous silicon nanoparticle.
摘要:
The present invention relates to a method for synthesising a compound of the following formula (I), where R is a methyl or ethyl group, n is 1 or 2, and X is a CH 2 or CD 2 group, from a compound of the following formula (II), where R and n are as defined above. The invention also relates to a method for assaying the compounds of formula (I) using a corresponding deuterated derivative as an internal reference, as well as to the use of ketal derivatives of compounds of formula (I) as a stable precursor, in particular in a flavouring composition.
摘要:
Nanovectors are disclosed that make it possible to simultaneously target, image, and treat cancerous cells using photodynamic therapy. Also disclosed are novel molecules (I) derived from porphyrins, silica-based nanoparticles comprising the same, and their use in photodynamic therapy.